FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and can be used to create aseptic osteonecrosis of the mandible when testing various ways of treating and preventing aminobisphosphonate osteonecrosis of jaws. Method of creating an experimental model of aseptic aminobisphosphonate osteonecrosis of the mandible consists in daily intraperitoneal administration of pamidronic acid to 3-6-month-old white rats at a dose of 40-80 mg / kg for 12-24 weeks.
EFFECT: method provides the creation of an osteonecrotic model allowing to increase the accuracy of the conducted studies without causing trauma (tooth extraction) in the absence of external clinical manifestations.
1 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MODELING ZERO STAGE OF OSTEONECROSIS OF THE LOWER JAW OF DRUGS ADDICTS | 2018 |
|
RU2680095C1 |
EXPERIMENTAL MODEL OF TREATING APSEPTIC BISPHOSPHONATE OSTEONECROSIS OF LOWER JAW IN LABORATORY WHITE RATS | 2017 |
|
RU2687744C1 |
METHOD FOR CREATING SEGMENTAL OSTEONECROSIS MODEL OF CONDYLE FORMING ANIMAL KNEE JOINT | 2004 |
|
RU2269824C2 |
METHOD FOR SIMULATING OSTEORESORPTION UNDER OSTEOGENESIS CONDITIONS | 2013 |
|
RU2524128C1 |
METHOD OF CONSERVATIVE TREATMENT OF BISPHOSPHONATE OSTEONECROSIS OF JAWS | 2017 |
|
RU2691075C1 |
METHOD FOR LEGG-CALVE-PERTHES DISEASE SIMULATION | 2016 |
|
RU2626567C1 |
METHOD FOR SIMULATING LIVER CIRRHOSIS IN EXPERIMENT | 2023 |
|
RU2817175C1 |
PHARMACOLOGICALLY ACTIVE SUBSTANCE OF ORGANISM-PROTECTION MATERIAL, METHOD OF PREPARATION THEREOF, AND THERAPEUTIC APPLICATION | 1990 |
|
RU2104704C1 |
METHOD FOR EXPERIMENTAL PERIODONTITIS SIMULATION | 2016 |
|
RU2625295C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF ROSUVASTATIN AND THIOCTIC ACID IN HYPOOESTROGEN-L-NAME-INDUCED NICTIC OXIDE DEFICIENCY | 2014 |
|
RU2568365C1 |
Authors
Dates
2018-05-11—Published
2016-11-09—Filed